Transenterix Inc (TRXC) Stock Price, Forecast & Analysis

NYSEARCA:TRXC

4.08
-0.46 (-10.13%)
At close: Mar 4, 2021
3.79
-0.29 (-7.11%)
After Hours: 3/4/2021, 8:04:00 PM
Overview Stock Chart Technical Analysis Fundamental Analysis Analyst Ratings Earnings Estimates Financials Ownership News

TRXC Key Statistics, Chart & Performance

Key Statistics
Market Cap582.53M
Revenue(TTM)2.76M
Net Income(TTM)-59.25M
Shares142.78M
Float115.69M
52 Week High6.95
52 Week Low0.28
Yearly DividendN/A
Dividend YieldN/A
EPS(TTM)-1.57
PEN/A
Fwd PEN/A
Earnings (Next)N/A
IPON/A
Sector
GICS SectorN/A
GICS IndustryN/A
GICS IndustryGroupN/A
GICS SubIndustryN/A
TRXC short term performance overview.The bars show the price performance of TRXC in the last week, last 2 weeks, last month, last 3 and 6 months. 1 week 2 week 1 month 3 months 6 months 0 200 400 600 800 1K

TRXC long term performance overview.The bars show the price performance of TRXC in the last 1, 2 and 3 years. 1 year 2 years 3 years 200 400 600 800

The current stock price of TRXC is 4.08 null. In the past month the price increased by 21.79%. In the past year, price increased by 837.93%.

Transenterix Inc / TRXC Daily stock chart

TRXC Technical Analysis

ChartMill assigns a technical rating of 7 / 10 to TRXC. When comparing the yearly performance of all stocks, TRXC is one of the better performing stocks in the market, outperforming 99.13% of all stocks.


Chartmill TA Rating
Chartmill Setup Rating
TRXC Full Technical Analysis Report

TRXC Fundamental Analysis

ChartMill assigns a fundamental rating of 3 / 10 to TRXC. TRXC scores quite bad on profitability, while its financial health is fine. Not spectacular, but in line with the averages.


Chartmill FA Analysis
Valuation
Growth
Profitability
Health
Dividend
TRXC Full Fundamental Analysis Report

TRXC Financial Highlights

Over the last trailing twelve months TRXC reported a non-GAAP Earnings per Share(EPS) of -1.5699999999999998. The EPS increased by 37.2% compared to the year before.


Industry RankSector Rank
PM (TTM) -2150%
ROA -73.93%
ROE N/A
Debt/Equity 0.04
Chartmill High Growth Momentum
EPS Q2Q%89.74%
Sales Q2Q%-59.78%
EPS 1Y (TTM)37.2%
Revenue 1Y (TTM)-82.07%
TRXC financials

TRXC Forecast & Estimates


Analysts
Analysts60
Price TargetN/A
EPS Next Y82.94%
Revenue Next YearN/A
TRXC Analyst EstimatesTRXC Analyst Ratings

TRXC Ownership

Ownership
Inst Owners6.4%
Ins Owners18.19%
Short Float %N/A
Short RatioN/A
TRXC Ownership

About TRXC

Company Profile

TransEnterix Inc. designs, develops and manufactures medical-devices. It offers SPIDER(R) Surgical System, a laparoscopic surgical platform that allows intra-abdominal triangulation procedures to be performed with articulating instruments through a single site. The company is primarily focused on the development and commercialization of SurgiBot, a patient-side minimally invasive surgical robotic system. TransEnterix Inc., formerly known as SafeStitch Medical, Inc., is based in United States.

Company Info

Transenterix Inc

635 DAVIS DRIVE SUITE 300

MORRISVILLE NC 27560

CEO: Anthony Fernando

Phone: 919-765-8400

Transenterix Inc / TRXC FAQ

What does TRXC do?

TransEnterix Inc. designs, develops and manufactures medical-devices. It offers SPIDER(R) Surgical System, a laparoscopic surgical platform that allows intra-abdominal triangulation procedures to be performed with articulating instruments through a single site. The company is primarily focused on the development and commercialization of SurgiBot, a patient-side minimally invasive surgical robotic system. TransEnterix Inc., formerly known as SafeStitch Medical, Inc., is based in United States.


What is the stock price of Transenterix Inc today?

The current stock price of TRXC is 4.08 null. The price decreased by -10.13% in the last trading session.


Does TRXC stock pay dividends?

TRXC does not pay a dividend.


What is the ChartMill rating of Transenterix Inc stock?

TRXC has a ChartMill Technical rating of 7 out of 10 and a ChartMill Fundamental rating of 3 out of 10.


Can you provide the PE ratio for TRXC stock?

Transenterix Inc (TRXC) does not have a PE ratio as the earnings reported over the last twelve months were negative (-1.57).